Faris A. Alkhayl
Buraydah, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Oxygenated 9H-carbazole-3-carbaldehyde scaffolds as cerebral cavernous malformation-relevant protein-protein interaction disruptors of the HEG1-KRIT1 interface.
Journal: Journal of computer-aided molecular design
Published: May 05, 2026
1H-Indazole-3-Carboxylic Acid Derivatives as Disruptors of the Oncogenic MTDH-SND1 Protein-Protein Interaction: An In Silico-to-In Vitro Study.
Journal: Cell biochemistry and biophysics
Published: April 17, 2026
Discovery of [1,2,4]triazolo[1,5-a]pyrimidine-based disruptors of the Skp2-Cks1 protein-protein interaction through integrated computational and experimental analysis.
Journal: Biochemical and biophysical research communications
Published: March 27, 2026
Structure-based discovery of diphenylpyrazines as disruptors of the Skp2-Cks1 protein-protein interaction: computational insights and biochemical validation.
Journal: Journal of computer-aided molecular design
Published: March 25, 2026
Structure-guided identification of 2-arylbenzothiazoles as disruptors of the oncogenic MTDH-SND1 protein-protein interaction.
Journal: Archives of biochemistry and biophysics
Published: March 10, 2026
Protein-protein interaction disruption as a next-generation antithrombotic strategy.
Journal: Journal of thrombosis and thrombolysis
Published: February 11, 2026
Disrupting the CBFβ-SMMHC-RUNX1 oncogenic protein-protein interaction in inv(16) AML: from fusion biology to targeted therapy.
Journal: Discover oncology
Published: January 26, 2026
Recent advances in indole-thiazole hybrid scaffolds: synthesis, molecular hybridization, and pharmacological potential.
Journal: Pharmacological reports : PR
Published: January 20, 2026
Disrupting PQBP1-eEF2 protein-protein interaction: From synaptic translation to immunity and cancer.
Disrupting PQBP1-eEF2 protein-protein interaction: From synaptic translation to immunity and cancer.
Journal: Neurochemistry international
Published: January 19, 2026
The CLOCK-BMAL1 complex in circadian regulation: structure, mechanisms, and therapeutic targeting.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: January 14, 2026
Disrupting the ASH2L-DPY30 PPI in cancer: structure, function, and therapeutic opportunities in H3K4 methylation.
Journal: Epigenetics & chromatin
Published: November 26, 2025
Disrupting the USP1-UAF1 deubiquitinase complex: a master regulator of replication stress and frontier target in cancer therapy.
Journal: Medical oncology (Northwood, London, England)
Published: October 13, 2025
Last Updated: 09/26/2026